Pharmaceuticals
-
Sharp fall in ovarian cancer mortality
Mortality from ovarian cancer in the UK is predicted to fall significantly this year compared with 2017, according to an analysis published today. Read more
-
Major antiviral trial for the most vulnerable
The UK is heading a major study of the benefits of antiviral treatments for high risk patients who contract COVID, it was announced today. Read more
-
Children’s lateral flow tests vary in reliability
COVID-19 lateral flow tests provided to children have sensitivity that "varies broadly" and is "substantially lower than reported by manufacturers", researchers warn today. Read more
-
WHO recommends two more COVID-19 treatments
A drug used to treat rheumatoid arthritis has been recommended for patients with severe or critical COVID-19, the World Health Organization announced today. Read more
-
Lung disease test for undiagnosed millions
A simple assessment can be used for accurate diagnosis of chronic obstructive pulmonary disease in many settings, according to a major global study. Read more
-
Ketamine may benefit severe alcoholics
Ketamine treatment may be effective for alcohol use disorder, alongside psychological therapy, according to a new study. Read more
-
Omicron tidal wave sweeping Europe
The Omicron variant is a “tidal wave” sweeping across Europe, the World Health Organization has warned. Read more
-
Common cold “key” to universal COVID vaccine
British scientists unveil new evidence today of how exposure to the common cold may help protect against COVID. Read more
-
Good results for T cell COVID-19 booster
A new COVID-19 booster vaccine may be effective against multiple variants, British scientists have announced. Read more
-
Magic mushroom drug found safe for therapy
Treatment of mental trauma or long-lasting depression with psilocybin may be one step closer after a new study found no detrimental effects. Read more
